Back to Search Start Over

Distinctive pattern of temporal atrophy in patients with frontotemporal dementia and the I383V variant in TARDBP

Authors :
Meike W. Vernooij
Yolande A.L. Pijnenburg
Laura Donker Kaat
Jeroen van Rooij
Elise G.P. Dopper
Resie M. L. van Spaendonk
Michael A. van Es
Petra E. Cohn-Hokke
Sven J. van der Lee
Merel O. Mol
Harro Seelaar
Wouter van Rheenen
Sebastiaan W.R. Nijmeijer
F. A. M. Hennekam
John C. van Swieten
Jan H. Veldink
Annemieke J.M. Rozemuller
Mark R. Janse van Mantgem
Rick van Minkelen
Neurology
Epidemiology
Clinical Genetics
Radiology & Nuclear Medicine
Human Genetics
Amsterdam Neuroscience - Neurodegeneration
Amsterdam Neuroscience - Neuroinfection & -inflammation
VU University medical center
Pathology
Human genetics
Source :
Journal of Neurology, Neurosurgery and Psychiatry, 92(7), 787-789. BMJ Publishing Group, Journal of Neurology, Neurosurgery, and Psychiatry, Mol, M O, Nijmeijer, S W R, van Rooij, J G J, van Spaendonk, R M L, Pijnenburg, Y A L, van der Lee, S J, van Minkelen, R, Donker Kaat, L, Rozemuller, A J M, Janse van Mantgem, M R, van Rheenen, W, van Es, M A, Veldink, J H, Hennekam, F A M, Vernooij, M, van Swieten, J C, Cohn-Hokke, P E, Seelaar, H & Dopper, E G P 2021, ' Distinctive pattern of temporal atrophy in patients with frontotemporal dementia and the I383V variant in TARDBP ', Journal of Neurology, Neurosurgery and Psychiatry, vol. 92, no. 7, pp. 787-789 . https://doi.org/10.1136/jnnp-2020-325150
Publication Year :
2021
Publisher :
BMJ, 2021.

Abstract

Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are closely related disorders, linked pathologically and genetically by the TAR DNA-binding protein-43 (TDP-43). Pathogenic variants in TARDBP encoding for TDP-43 have been described less frequently in FTD than in ALS, and clinicopathological studies are scarce.1 We previously observed a high frequency of the I383V variant in TARDBP in a Dutch cohort of FTD patients.2 Here, we provide further evidence for the pathogenicity of this variant and present its clinicopathological characteristics. We ascertained all FTD (n=13) and ALS patients (n=4) with the I383V variant (NM_007375.3: c.1147A>G, p.Ile383Val) in TARDBP from three university medical centres in the Netherlands (Amsterdam, Rotterdam and Utrecht), as identified by whole-exome or whole-genome sequencing in either clinical or research setting. Concurrent pathogenic variants in 20 other genes associated with ALS, FTD or other forms of dementia were excluded in all patients. Brain imaging (CT or MRI) was available for all FTD patients. Quantitative assessment of volume loss across lobar brain regions was performed in those patients with T1-weighted MRI images of sufficient quality (n=5), and compared with a gender-matched/age-matched reference population. Family histories were classified into adjusted Goldman categories, which were described previously.2 Additionally, we performed extensive genealogical research to investigate possible relatedness between the index patients. Brain autopsy and routine immunohistochemistry was performed for two FTD patients by the Netherlands Brain Bank. One patient (4M) was reported previously as M008015-001.1 Detailed information on the genetic, neuroimaging, genealogical and pathological analyses can be found in the1. ### Supplementary data [jnnp-2020-325150supp001.pdf] ### The variable clinical phenotype and reduced penetrance of the I383V variant All 13 FTD patients with the I383V variant in TARDBP presented with a combination of behavioural changes and semantic deficits. The diagnoses of semantic variant of primary progressive aphasia (svPPA) are intriguing since this is usually considered a sporadic disorder. One patient (4M) showed additional motor …

Details

ISSN :
1468330X and 00223050
Volume :
92
Database :
OpenAIRE
Journal :
Journal of Neurology, Neurosurgery & Psychiatry
Accession number :
edsair.doi.dedup.....6b9678ff512b2f72850bfd0056f262f0
Full Text :
https://doi.org/10.1136/jnnp-2020-325150